Biglycan Antikörper (Middle Region)
-
- Target Alle Biglycan (BGN) Antikörper anzeigen
- Biglycan (BGN)
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human, Ratte, Maus, Hund
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Biglycan Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- BGN antibody was raised against the middle region of BGN
- Aufreinigung
- Affinity purified
- Immunogen
- BGN antibody was raised using the middle region of BGN corresponding to a region with amino acids ISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ
- Top Product
- Discover our top product BGN Primärantikörper
-
anti-Biglycan (BGN) (AA 1-368) antibody
BGN Reaktivität: Human WB, ELISA, IP, IHC (p) Wirt: Maus Monoclonal 4E1-1G7 unconjugated
anti-Biglycan (BGN) (AA 230-366) antibodyBGN Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (AA 53-166) antibodyBGN Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (C-Term) antibodyVerified BGN Reaktivität: Human, Maus ELISA, IF Wirt: Ziege Polyclonal unconjugated
anti-Biglycan (BGN) (AA 101-200) antibodyBGN Reaktivität: Human, Ratte, Maus, Kaninchen WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (AA 148-176) antibodyBGN Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB19735 unconjugated
anti-Biglycan (BGN) (AA 38-300) antibodyBGN Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) antibodyBGN Reaktivität: Human, Ratte, Maus WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (AA 1-368) antibodyBGN Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) antibodyBGN Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
BGN Blocking Peptide, catalog no. 33R-4147, is also available for use as a blocking control in assays to test for specificity of this BGN antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BGN antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- Biglycan (BGN)
- Andere Bezeichnung
- BGN (BGN Produkte)
- Synonyme
- DSPG1 antikoerper, PG-S1 antikoerper, PGI antikoerper, SLRR1A antikoerper, BG antikoerper, BSPG1 antikoerper, bgn antikoerper, zgc:91989 antikoerper, dspg1 antikoerper, pg-s1 antikoerper, slrr1a antikoerper, xbgn antikoerper, BGN antikoerper, zgc:77123 antikoerper, DKFZp468I2427 antikoerper, biglycan antikoerper, biglycan L homeolog antikoerper, biglycan a antikoerper, biglycan S homeolog antikoerper, biglycan b antikoerper, BGN antikoerper, Bgn antikoerper, bgn.L antikoerper, bgna antikoerper, bgn.S antikoerper, bgn antikoerper, bgnb antikoerper
- Hintergrund
- The protein encoded by this gene is a small cellular or pericellular matrix proteoglycan that is closely related in structure to two other small proteoglycans, decorin and fibromodulin.
- Molekulargewicht
- 37 kDa (MW of target protein)
- Pathways
- Glycosaminoglycan Metabolic Process
-
